Medical Cyclotron by Reina A. Jimenez V
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
3 
Medical Cyclotron 
Reina A. Jimenez V 
Policlínica Metropolitana,  
Venezuela  
1. Introduction  
In this chapter we intend to illustrate the reader about the use of Cyclotrons to produce easy 
handle radioisotopes, to be used for medical diagnostics or therapies in Nuclear Medicine. 
Firstofall, we will describe different activation processes to generate artificial radioisotopes, 
characteristics needed to be safely used in medicine, such as the relationship between 
fathers and daughters that can compromise patient or environment health. It also will be 
describe radioisotopes desire behavior inside human body in order to clarify which isotopes 
can be activated or not in a cyclotron facility to be used in human medical applications.  
Nuclear Medicine radioisotopes must fulfill four main characteristics in order to be easy 
handle by operators and be easily and quickly disposed by patients and not to represent 
environmental radioactive contamination harm, so they have to have:   
1. Low activity 
2. Low energy 
3. Short half life 
4. Decay to a stable daughter 
In Nuclear Medicine, equipment also has to have a high sensitivity to small amounts of 
radiation and to different types of radioisotopes. The ideal radioisotopes must be easily 
eliminated by the patient just after the study has been done in a short period of time which 
is a function of the physical half life of the isotope and the patient excretion system. The 
total time elapse for patient elimination of any trace of radioisotope used for study is known 
as Effective Half Life Time Tଵ/ଶୣ୤୤  and is related to the time isotope population is reduced to its 
half due to the radioactive decay of father to daughter (Physical Half Life) Tଵ/ଶ୮୦୷ and the time 
patient systems needs to eliminated of isotope from it system (Biological Half Life) ଵܶ/ଶ௕௜௢ in 
this way:  ͳଵܶ/ଶ௘௙௙ = ͳଵܶ/ଶ௣௛௬ + ͳଵܶ/ଶ௕௜௢ 
So it is not easy to find natural occurrence radioisotopes to fulfill this equation in order to 
make Tଵ/ଶୣ୤୤  shorter than biological times of cellular repair. Fortunately in mid 20Th century, 
there was a huge development of activation processes when man learn how to manipulate 
atom and its nuclei, so now we have a big amount of radioisotopes for an equally big 
amount of pacific applications. There are two kinds of manmade machinery capable of 
modify stable nuclide: Nuclear reactors and particle accelerators. Accelerator can also be 
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divided into two big groups: Linear accelerators and spiral path accelerators or Cyclotrons.  
The radioisotopes used in Medicine can be from natural ocurrences like 137Cs (used in the 
last century in Teletherapy machines and in low dose rate brachytherapy) or 192Ir (used 
nowadays in high dose rate brachytherapy), or can be produced in Reactors or Cyclotrons. 
Most common reactor products used in Medicine are: 
For diagnostic purposes: 51Cr, 125I, 131I, 59Fe, 42K, 177Lu, 99Mo (fission product), 75Se, 24Na, 
99mTc, 133Xe (fission product), 159Yt. 
For therapeutic purposes: 213Bi, 60Co, 165Dy, 169Er, 125I, 131I, 192Ir, 212Pb, 177Lu, 103Pd, 32P, 188Re, 
186Re, 153Sm, 89Sr (fission product), 90Y (fission product). 
For diagnostic and therapeutic or other purposes: 60Co, 166Ho, 125I, 99Mo (fission product), 177Yt. 
Most common radioisotopes produced in Cyclotrons used in Medicine are: 
For diagnostic purposes: 11C, 13N, 15O, 18F, (PET studies), 64Cu, 67Ga, 68Ga, 111In, 123I, 124I, 
81mKr, 99Mo (activation product), 82Rb, 201Th. 
For therapeutic purposes: 67Cu. 
For diagnostic, therapeutic or other purposes: 57Co, 82Sr, 68Ge. All of them have to fulfill the 
four conditions mentioned above. 
Knowing all this restrictions radioisotope has to accomplish, to be safely used in human, 
now we can talk about the characteristics of a cyclotron to produce such an isotope. Later in 
this chapter we will describe such an installation regarding shielding, environmental safety, 
radiopharmacy lab, etc. 
In Venezuela, we start to install the first baby cyclotron for medical purposes on 2001, so our 
last section of this chapter is to illustrate how  this installation works and how its programs 
has been accomplish to the present date. 
2. Basic physics of particle activation   
“Particle activation” means “artificial radioactivity” or “man made radioisotopes”, far away 
from “natural radioactivity” which is a basic characteristic of our Universe, that has been 
present all over the universe history, and it contains only four natural decay series 
characterized by their numbers of nucleons  as is shown in Table 1., artificial radioactivity is 
a very young phenomena born in 20th century.  
 
Series Parent Nucleons Stable end 
THORIUM 232Th90 4n 208Pb82
NEPTUNIUM 237Np93 4n+1 209Bi83
URANIUM 238U92 4n+2 206Pb82
ACTINIUM 235U92 4n+3 207Pb82
Table 1. Natural decay series. 
Firstofalll we have to define radioactivity: It is a property of nature in which atoms have 
such a big amount of energy so they need to discharge it to the surrounding media. The aim 
of it is to become stable, i.e. have the less amount of energy need to exist, because atom 
stability is the more cost/efficiency retail in matter. Atom then has design some method to 
discharge energy and diminish it energy level to become stable. Radioactive atoms can emit 
some energy packs splitting them in pieces of several dimensions and energy content to 
reach its stability: 
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Fig. 1. Decay mode of radioactive atoms to reach stability.The action of atoms to split means 
mass and energy transfer to media. For example, in a 226Ra atom energy excess push it to 
split out a 42 He  nucleus (an alpha particle) and 1.4 MeV package of pure energy and another 
atom of 222Rn, so where there was one atom now there are three different species born out it 
mass and energy 
There are several methods for atoms to transfer energy to the media. Remember Einstein´s 
principle of ܧ = ݉ܿଶ, which means energy is matter and matter is energy. So in their 
attempt to become stable emits energy/matter to discharge it excess in several ways as in 
figure 1. 
And scientist began to use this atom fraction to hit different nucleus of known atoms and to 
observe which was the results of the reverse experiment.  
Back in 1929, Ernest Lawrence device a Cyclotron to fulfill his own need to generate high 
speed ions without needing high voltages he has not access to in Berkeley University. This 
history began 10 years before when Lord Rutherford used alpha particles coming from 
Madame Curie´s 226Ra as projectiles to impact a Nitrogen nucleus to transform it into Oxygen. 
 
 
Fig. 2. Lawrence´s illustration about Rutherford Experiment. 
Radiactive Atoms
Discharge
Heavy ions βα γ
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In the same line of thoughts, Lawrence needs more projectiles to study this new phenomena. 
That 15th century dream of turning Lead into Gold was now though to be possible. 
Radioisotopes not always decay to a stable daughter but they continue trying, emitting 
different kinds of particles until they reach stability. In the sake for such stability they 
transform themselves into a partner they “believe” is more stable: The fifteen Century 
“Transmutation of Matter” occurs not for lead to become gold but something alike. Men 
made transmutation, which arise to be only the modification of the “positive electricity in 
the atomic nucleus”, as Lawrence said.1 He described his method of accelerating particles in 
Cyclotron as “resonance method” or “method of multiple acceleration:  
 
 
Fig. 3. Lawrence description of Cyclotron accelerating method. 
Few time pass, until man used that newly produce radioactive material to treat and 
diagnoses different affections. John Lawrence, Ernest brother was the first to use his brother 
product 32P  to treat leukemia starting the medical applications of cyclotron products. 
Method of particle activation then, need  a Nuclear Reactor or an accelerator (Cyclotron, 
Syncrothron or Linac) to be produced: Nuclear Reactor is an installation in which big rod of 
natural occurring radioisotopes are set inside a pile with some stable, neutron absorbent, 
material. The radioisotopes (Th, U)  initiates a chain reaction, the stable rod (such as carbon 
(graphite)) are used to absorb chain reaction debris, in order to moderate the amount of 
energy (heat) that is produce by nuclear reactions.  
They are considered of two kinds: Power Nuclear Reactors which are dedicated to use the 
energy to produce electricity, for example, boiling water to move turbines with the steam 
and in this way produce electric power. Nuclear Research Reactors are used as a source of 
neutron of different energies to impact different atoms nuclei to become radioactive. In both 
cases they need the fission product from the original radioactive atom to undergo the chain 
reaction. For example, 235U absorb a neutron, it become 236U and this split into 92Kr and 141Ba 
with several neutron that can impact other 235U and become 236U to repeat the reactions. 
                                                                 
1 E.O.Lawrence:(1939) University of California: ”Artificial Radiactivity” speech. 
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Fig. 4. Materials for particle absorption in a Reactor. 
 
Fig. 5. Percentage of activation products worldwide coming from Reactors or Cyclotrons 
including medical, industry and research production. 
In the other hand, cyclotron are electrical machines that generates particle acceleration thru 
helping them  to undergo a circular or elliptical path in which particles gain energy by 
external manipulation of electric an magnetic fields.   
Cyclotrons comes from a bigger family of electrical machines called Accelerators, because 
the make particles to gain energy letting them gain kinetic energy by applying electrical and 
magnetic fields to the particle trajectory so it can absorb energy from the media where it is 
travelling. Back to high school physics we can understand easily how cyclotrons accelerate 
particles: you must remember that force in an electrical field is:  
 ܨ = ݍܧ (1)  
And also you remember that when you have and electrical and magnetic fields you can 
write  
 ܨԦ = ݍሺݒԦ × ܤሬԦሻ    (2) 
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Fig. 6. Cyclotron schematics: a) ion input location, b) ܤሬԦ = ݒԦݔܨԦ, c) Ion path. 
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Where q is the charge, v is the velocity and B is the magnetic field 
Or in its escalar form 
 ܨ = ݍݒܤ    (3) 
But you know that when you send a particle in a circular path also the centrifugal force 
yields:  ܨ = ݉ݒଶݎ  (4)
Where m is the mass of the particle to be accelerated and r is the radius of the circular path. 
If you equal 3 with 4 you can obtain the radius you need for a particular energy you  
want ݎ = ݉ݒݍܤ  (5)
Velocity has two components, linear that is tangential to the spiral trajectory and angular 
that is about circular path cover by the particle, so  
 ݒ = ߱ݎ    (6) 
Where ω is the angular velocity and  
 ߱ = ʹߨ݂     (7) 
Where f is the angular frequency of the movement, so using 3 and 4 we can know about 
cyclotron frequency ݉ݒଶݎ = ݍݒܤ (8)
Because potential energy has to become kinetic energy so,  ݍܸ = ݉ݒଶʹ  (9)
Where V is the potential between the d´s where the particle gain energy ݒଶ = ʹݍܸ݉ (10)
 ݓℎ݁ݎ݁	ܸ = ܧݎ = ݒܤ    (11) 
So  ݒ = ௥௤஻௠ = ߱ݎ = ʹߨ݂ݎ and finally ݂ = ݍܤʹߨ݉ (12)
And remembering Einstein, particles with this energies travels near speed of light ݂ = ݍܤʹߨߛ݉଴ (13)
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With  ߛ = ͳටͳ − ሺݒ ܿሻ⁄ ଶ (14)
3. Methods of particle activation   
Alpha particle Bombardment: Using natural produced alpha particles light elements can be 
activated, and as far as Pottasium. Such projectile induce the emission of a proton, the 
liberation of energy and a transmutation, not all the transmutation products are radioactive 
Neutron Capture: Firstly observed when matter is bombarded with deuteron, which also 
involve the emission of a proton, as we will illustrate forward. 
4. Reaction of particle activation   
1. Nuclear Activation in Reactors:  
( ),n γ
 
Reaction: Radioactive capture: Undergo mostly by thermal neutron 
59 1 60
29 0 29Co n Co γ+ ⎯⎯→ +           (s=36 b) 
98 1 99
42 0 42Mo n Mo γ+ ⎯⎯→ +           (s=0.12 b) 
In such a reaction father and daughter are of the same chemical species so they cannot be 
separated, reason why the target must have a very high enrichment rate. 
( ),n α  Reaction followed by β- decay 
130 1 131 131
52 0 52 53Te n Te I
β γ−+ ⎯⎯→ ⎯⎯⎯→ +  
Tellurium and iodine are easily chemical separated  
( ),n p  Reaction: Neutron Capture 
32 1 32 1
16 0 15 1S n P H+ ⎯⎯→ +  
58 1 59 1
28 0 28 1Ni n Co H+ ⎯⎯→ +  
This is similar to the first reaction produced in his cyclotron that be named “neutron 
capture” despite he was using deuterium as projectile, he observed that neutron stayed 
inside target nuclear and the remaining mass was expel as a proton. 
( ),n α  Reaction: Light fission 
6 1 3 4
3 0 1 2Li n H He+ ⎯⎯→ +  
2. Activation Equation:  
1 ( )act
dN
N t
dt
σ= Φ  
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Where: 
N1      = Atoms of the target 
Φ     = Neutron flux 
actσ = Activation cross section 
( )N t = Number of atoms activated in a time period elapsed t 
So, the number of activated atoms is: 
1
( )(1 )act
tN t e
N
λσ
λ
−−= Φ  
And the activity of the sample is: 
1A Nλ= = ( )(1 )act tN t e λσ −Φ −  
t is the time of irradiation  in seconds 
A is the activity at the saturation value that is a function of reactor neutron flue at which 
target has been exposed. 
3. Nuclear reaction in cyclotron production 
( ),p n  Reaction 
18 1 18 1
8 1 9 0O H F n+ ⎯⎯→ +  
( ),d α  Reaction: 
20 18 4
10 9 2Ne F He+ ⎯⎯→ +  
( ),p α  Reaction 
14 1 11 4
17 1 6 2N H C He+ ⎯⎯→ +  
16 1 13 4
8 1 7 2O H N He+ ⎯⎯→ +  
( ),d n  Reaction 
14 2 15 1
7 1 8 0N H O n+ ⎯⎯→ +  
( ),2d n  Reaction 
68 2 65 0
30 1 31 12Zn H Ga n+ ⎯⎯→ +  
124 1 123 1
52 1 53 02Te H I n+ ⎯⎯→ +  
( ),2nα  Reaction 
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65 4 67 1
29 2 31 02Cu He Ga n+ ⎯⎯→ +  
5. Differences and similarities between reactors and cyclotrons 
Cyclotron is not the only way of activating matter. Going through history, side by side  
cyclotron development in America, Europe was devoted to the natural radioactive material 
discovered by many scientists, from Madame  Curie (1898), Pierre, Irene and also Joliot  till 
Enrico Fermi, Otto Hahn, Lise Meitner and Fritz Strassman (1939). Neils Bohr and Jhon A.  
Wheeler published their explanation of the method for moderating, “modulating”, chain 
reactions in a paper published only 2 days after WWII starts in 1939. The first reactor was 
then brought into criticality in Fermi´s Lab on December 2nd, 1942 in very controlled 
experiment including radiation safety and protection considerations. Proving that chain 
reaction can be controlled, it was matter of time to find uses for the products obtain from a 
nuclear reactor. The neutron from reactors are projectiles for many (n,p), (n,β), reactions to 
produce many radioisotopes. So time has come to begin talking about which of all this 
radioactive products can be used in medicine. The first radioactive material used in humans 
with medical purposes was 226Ra, (1898) used by Madame and Mousier Curie to treat skin 
lesion they called “benign”. Their daughter Irene used 214Bi to measure blood flow, this two 
products come directly from the 238U natural decay series. By the artificial radioisotopes 
side, the first one was that 32P John Lawrence (1929) used to treat leukemia.  After of it, a lot 
of radioisotopes and a lot of uses have been developed for diagnostic and therapy uses,  so 
for this time,  we can say that the radioisotopes used in Medicine distributions is as it is 
shown in Table 2: 
 
 Reactors Produced Cyclotrons Produced 
Fission 
Products 
Neutron activation 
Diagnostic 
Purposes 
133Xe, 99Mo 51Cr, 125I, 131I, 89Sr, 153Sm, 
59Fe, 177Lu, 42K, 75Se, 24Na,  
99mTc, 159Yt 
11C, 13N, 15O, 18F, 57Co, 
82Sr, 68Ge 64Cu,67Ga, 
68Ga, 111In, 123I, 124I, 
81mKr, 82Rb, 201Tl 
Therapeutic 
Application 
89Sr, 90Y 213Bi, 60Co, 165Dy, 169Er, 125I, 
131I, 192Ir, 212Pb, 177Lu, 103Pd, 
32P, 186Re, 188Re, 153Sm 
67Cu, 57Co, 82Sr, 68Ge 
Table 2. Distribution of the radioisotope production for medical applications. 
Like the Curie’s began using their newly discovered natural radioisotopes to treat cancer 
lesion in the skin, very short time after the construction of the cyclotron and the production 
of its radioisotopes,  makes  the medical applications  to be easily spread. 
But there is another mechanism for particle activation and it comes from the nuclear reactor 
where a bunch of natural radioisotopes “bars” are used to produced spontaneous fission 
products to aim the nucleus of stable atom or its electronic crown. 
Nowadays reactors are the core of the nuclear power plants, but in their beginnings they 
were developed for research proposes to military applications only. Due to the natural 
“nuclear fuel” reactors were better in cost/efficiency fashion and in the late 30’s and early 
40’s many budgets and efforts were driven to their construction to regulated nuclear chain 
reaction and its control, until the atomic bomb development to win WWII. 
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But passing thru that dark hour, all the money spend in its development seems to be not 
that important. 
And cyclotron has to compete (and win) against reactors that were redeeming themselves 
by producing “atoms for the peace” trying to justify the large budget assign to them during 
WWII. 
And for a long period of time the guilt drop the balance to reactors side until middle 70’s 
when positron emission tomography arised based in a component containing 18F: 18FDG 
(Fluorodexoxy glucose). 
This isotope was only produced in cyclotron and the compound could be synthetized in a 
straight forward relative easy way. 
This made cyclotrons an Hospital equipment because, due to the short half-life of 18F, it was 
necessary to stablish the supplier so near to the costumer as it can be, and being a hospital a 
places were pureness and asepsie is well know, and treat with reverential respect, which 
other place would be better to activated pure 18F and synthetize the 18FDG in a sterile form 
to be safe to apply in human. 
And between 1929 and 1974 lot of things happened to cyclotron to develop its actual 
characteristic. From Lawrence Cyclotron to Hospital one, until CERN´s a lot of energy has 
pass through. 
 
   
                    a)                                                    b)                                                        c) 
Fig. 7. Different cyclotron size: a) Lawrence´s first one,  b) Venezuela First one (courtesy of 
Dorly Coehlo), c) Fermi National Laboratory at CERN. 
And size matters, and Cyclotrons win as best hospital candidates due to Reactors are bigger, 
harder and difficult to be set in a hospital installation. Can you imagine a nuclear reactor 
inside a health installation? Radiation Protection Program will consume all the budget 
available. Size, controlled reactions, electrical control, made cyclotrons easy to install, and 
baby cyclotrons come selfshielded so hospital don´t need to spend money in a extremely 
large bunker. Now on, we are going to talk about our first experience with the set up  of a 
baby cyclotron for medical uses inside the first PET installation in Latin America. “Baby” 
means its acceleration “D” diameters are  suitable to be set inside a standard hospital room 
dimensions, with all its needs to be safetly shielded for production transmision and 
synthetized for human uses for imaging in Nuclear Medicine PET routine. When we ask 
why Cyclotrons are better than reactors for radioisotopes production to be used in Medicine, 
we also have to have in mind that they has: 
1. Less radioactive waste 
2. Less harmful debris 
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3. They can be installed inside hospital decentralizing radioisotope production.  
4. Almost zero risk of nuclear accidents (Because there is no chain reaction to control) 
5. There is no risk of nuclear proliferation 
Compare with a reactor. 
 
  
 
 
Fig. 8. Artificial radioisotopes. 
 
  
 
                                      a)                                                                                b) 
 
Fig. 9. Difference in size between a) Venezuelan medical cyclotron (courtesy of Indira Lugo) 
and b)Venezuelan research reactor (in desuse). 
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Medical Cyclotrons generally often comes with 4 targets to activated: Fluor 18, Oxigen 15,  
Nitrogen 13 and Carbon 11. In Venezuela we have one with only one target to activated 
fluor 18  to sintethized 18FDG, for PET studies.  
6. Activation products medical uses 
Remembering what we want for a radioisotopes to be safely used in medicine, Natural 
decay series has had a very bad performance. For example, 226Ra was used in Medicine until 
users realized that its daughter was 222Rn, a gas. Since 226Ra was encapsulated in stainless 
steel tubes the accumulation of Radon from Radium decay inside the tube, cause the 
gaseous pressure to increase in a non controlled way, so more than 10 years after its 
encapsulation, the gas pressure was so high as to break the capsule and escape. So as 222Rn is 
a radioactive gas and it half life is not short (almost 4 days), contamination was hard to 
contain, so Radium use was declined.  
 
 
Fig. 10. Radium Tubes. 
Activation products from Cyclotrons are in general of short half life, so the control can be focus 
in the energy users can handle. In such a way, we can say activation products can be tailored 
to our needs. But medical uses are little complicated. Nuclear Medicine consist in mix the 
radioisotope with a pharmaceutical product which is characterized by the organ they are 
going to address the isotope. What Nuclear Medicine really needs is to send the radioisotope 
to get inside the organ we want to study, and as the radioisotope is inside a molecule that can 
be metabolized by this organ, this metabolization function can be easily watch and measure 
with the appropriate radiation detectors. The name “radiopharmaceuticals” refers to the 
metabolically stable combination of a biochemical molecule to which radioisotope in bind that 
act as the vehicle through which, organ of interest can be reach. There are several mechanism 
for the radioisotope to join the address molecule such as: 
1. Ionic compound: In which the radioisotopes determine the metabolic route to be follow 
as in 131I to thyroid uses, because thyroid likes iodine and do not distinguish between 
different isotopes of the same element iodine. 
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2. Isotopic Exchange: In which the radioactive isotope goes to replace the stable isotope of 
it own species  
3. Incorporation: In which radioisotope  get inside the molecule but not interacting with 
the chemical compound, so it did not change its structure neither biochemical nor 
physical  properties 
4. Coprecipitation: In which radionuclide is precipitated in the same reaction with the 
chemical compound. Many are the radioisotopes that can be combined with different 
molecules to be address to different parts of human body with diagnostic or therapeutic 
purposes,  so we can group them as in the table below: 
Imaging: 
 
Isotope Symb
ol  
Z T1/2 Decay 
mode
Photons 
Energy 
β energy Uses 
Fluorine-18  18F 9 109.77m β+ 511 
(193%) 
0.664 (97%) PET: Cancer detection and 
monitoring of treatment 
progress, in flurodexoxiglucose. 
(FDG)  Tracer  in flurothymidine 
(FLT) and fluromisonidazole (F-
MISO), and  18F-choline 
Gallium-67 67Ga 31 3.26d EC  93 (39%) 185 (21%), 
300 (17%) 
SPECT: Tumor imaging, 
infections localization 
Krypton-81m 81mKr 36 13.1s IT 190 (68%) - Refrigerant  
Rubidium-82 82Rb 37 1.27m β+ 511 
(191%) 
3.379 (95%) Tracer in positron emission 
tomography 
Technetium-99m 99mTc 43 6.01h IT 140 (89%) - Pulmonary ventilation studies. 
Indium-111 111In 49 2.80d EC 171 (90%) 245 (94%) Brain studies, infection and colon 
transit studies. 
Iodine-123 123I 53 13.3 h EC 159 (83%) - Gamma emitter: diagnosis of 
thyroid function, without the 
beta radiation of I-131. 
Xenon-133 133Xe 54 5.24d β- 81 (31%) 0.364 (99%) Studies of pulmonary function 
and organic blood flow. 
Thallium-201 201Tl 81 3.04d EC 69-83* 
(94%) 
167 (10%) Diagnostic aid in the form of 
thallous chloride TI 201 
Carbon-11 11C 6 20.39m β+ -- 0.96 (100%) PET: Studies of brain physiology: 
epileptic focus, dementia, etc 
Nitrogen-13 13N 9 9.965m β+ -- 1.2 (100%) PET: Cardiology 
Oxygen-15 15O 8 122.24s β+ -- 1.8 (100%) PET: Cardiology and cancer 
detection 
Cooper-64 64Cu 29 13 h β+ -- 0.65 (61%)
0.58(39%) 
genetic studies: copper 
metabolism: Wilson's and 
Menke's diseases.  PET: tumours, 
and therapy. 
Cooper-67 67Cu 29 2.6 d β− -- 0.56 (100%) Beta emitter therapy  
Gallium-68 68Ga 31 68 min β+ -- 1.90 (100%) PET: tumor detection, daughter 
in 68Ge generator 
Germanium-68 68Ge 32 271 d EC -- 0.1 (100%) 68Ga generator parent 
www.intechopen.com
 
Medical Cyclotron 61 
Therapy: 
 
Isotope Symbol  Z T1/2 Decay 
mode 
Photons 
energy 
β energy 
Yttrium-90 90Y 39 2.67d β- - 2.280 (100%) 
Iodine-131 131I 53 8.02 d γ, β- 364 (81%) 0.807 (100%) 
Table 3. Common Isotopes Used in Nuclear Medicine for diagnostic studies or therapy 
procedure. 
In the table above we can see some radioisotopes that say they are parent or daughter in a 
generator, but what is a generator? 
7. Generators 
In Nuclear Medicine environment, sometimes is useful to have a regular provision of 
radioisotopes for studies to be performed without the restrictions of providers time 
dependences, for example when studies has to be done anytime of the day in emergency 
conditions. If physician suspects an infection in a patient admitted in Emergency Room, it 
will be of utmost usefulness to have Nuclear Medicine images done with appropriate 
radiopharmaceuticals to solve the question about the most effective treatment to be offer to 
the patient. Either way, sometimes in Cardiology it is of high importance to know about 
percentage of isquemic muscle, but patient has not the luxury of time to undergo a 
catheterism, so it is more effective and quick to have Nuclear Medicine  images and cine of  
the heart. In many cases like this, have a good availability of radiotracers make the 
differences between a correct and opportune answer or a misdiagnosis. 
This is the reason why radioisotopes generators have become so popular beside the fact that 
in countries like Venezuela where there is no nuclear production, sometime become very 
hard to warranty a regular supply. A radioisotopes generator is a device in which you can 
contain a pair father/daughter in which the daughter is the product of interest for studies 
purposes and father only come to generate the full amount of daughter needed. Due to the 
short half life we need for the radioisotope to be safe handle in hospital conditions, it would 
be useful to find a pair father and daughter that warranty  the in time provision of 
radioisotope needed. During the generator useful life father has to decay completely to the 
useful daughter so it can be easily recharged, disposed or returned to provider. Such pair 
must that accomplish some conditions like: 
1. Father has to have long enough half life (physical) such as to overcome travel time from 
provider to user. In this way father will be generating enough amount of daughter that 
can be extract in site for studies and will continue generating daughter to fulfill the 
needs for its entire useful time. 
2. Father must be shipped in pyrogen free condition 
3. Daughter has to decay in a sufficient short life be secure for image acquisition and 
radiation protection of patient 
4. Father and daughter have to have different chemical characteristics so the can be easily 
separate to be sure the daughter is so pure to be safe for human applications and there 
are no traces of the father in the injection solution.  
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5. This separation must be passive in terms of no violent chemical reaction must be 
involved in the process, to warranty the chemical safeness  
6. The daughter must be eluted with a human compatible solution to warranty biological 
safeness 
7. The human intervention would be minimum to warranty the minimum exposure to 
radiation 
8. Radiation protection now is not the unique concern but chemical and biological 
protection is also very critical 
9. The granddaughter must be of very long time as to be consider stable  
After radiochemist discover some pairs of father/daughter that accomplish this 
characteristics, some were built in a shielded container to be send to hospital to extract the 
daughter. It makes radiosotopes clinically useful and commercially available.  
Medicine is not the only client for radioisotopes generator, also we will talk about some 
other uses of them that are increasing its popularity thru years. So let´s have a few words 
about their relationship. As in any father/daughter relationship there are different kinds, in 
radioactive “family” we can talk about two kind of equilibrium that this families reach, they 
are called transient and secular equilibrium. Equilibrium meaning when father and 
daughter exist in significant proportion to one another.  Secular equilibrium is a condition 
that they can reach when father physical half life is 2 or 3 magnitude orders greater that 
daughter´s (100 to 1000 times greater). It means when daughter decay many times father 
seems no to be affected. While transient equilibrium is a condition that is reach when father 
physical half life is about 10 times daughter´s. It is, when daughter decay few times father 
can decay to its 50%, i.e a full half life.  Note that if physical half life of the daughter is larger 
that the father equilibrium can never be reach because father will be ever alone. 
Secular Equilibrium Generators ܩ݁ ఌ,ଶ଻ହௗሱۛ ۛۛ ሮ ܩܽ ఉశ,ఌ,ఊ,ଵ.ଵସ	௛ሱۛ ۛۛ ۛۛ ۛۛ ሮۛ ܼ݊଺଼଺଼଺଼  ܴܾ ఉశ,ఌ,ସ.଻௛ሱۛ ۛۛ ۛۛ ሮ ܭݎ ఊ,ଵଷ௦ሱۛ ሮۛ ܭݎ଼ଵ଼ଵ௠଼ଵ  ܵݎ ఌ,ଶହௗሱۛ ሮۛ ܴܾ ఉశ,ఌ,ఊ,଻ହ௦ሱۛ ۛۛ ۛۛ ሮۛ ܭݎ଼ଶ଼ଶ଼ଶ  ܵ݊ ఌ,ଵଵ଼ௗሱۛ ۛۛ ሮ ܫ݊ ఊ,ଵ.଻	௛ሱۛ ۛۛ ሮ ܫ݊ଵଵଷଵଵଷ௠ଵଵଷ  
Transient Equilibrium Generators ܯ݋ ఉష,ఊ,଺଻௛ሱۛ ۛۛ ۛۛ ሮ ܶܿ ఊ,଺	௛ሱۛ ሮ ܶܿଽଽଽଽ௠ଽଽ  ܹ ఌ,ଶ଻ହௗሱۛ ۛۛ ሮ ܴℎ ఉష,ଵ଻	௛ሱۛ ۛۛ ሮۛଵ଼଼ଵ଼଼ ܱݏଵ଼଼  
Although this last one has a promising future in metastatic disease pain reliever and as a 
monoclonal antibody marker, the most popular generator in Nuclear Medicine is the Mo/Tc 
one. It is Techenetium is highly biocompatible in the Nuclear Medicine fashion so it can be 
used in a large number of studies.  
This Mo/Tc generators can be produced in cyclotrons or reactors and as in many 
radioisotope produced, the advantages of using that from cyclotron in front of that of 
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reactors is that in cyclotron you can use 98Mo enriched target to be activated by neutron 
irradiation in a (n,γ) reaction, while 99Mo coming from fission include very expensive 
production beside the complex regulations due to the highly enriched Uranium targets. 
 
TARGET ORGAN  99mTc RADIOPHARMACEUTICALS 
Brain  DTPA (DiethylTriaminoPentacetic Acid) 
(CaNa399mTc) 
Brain Perfusion ECD (EthylCysteinate Dimer) 
Kidneys DTPA (DiethylTriaminoPentacetic Acid) 
Calcium Gluconate 
Lactobionate 
Calcium Glucoheptonate 
Manitol 
Dextrose 
Penicilamine 
2,4 dimercaptosuccinic acid 
Liver 99mTc Sulphur 
Sn Hidroxide 
Sodium Phytate 
Sodium Calcium Phytate 
Lungs Inorganic Macroagregate 
Albumin Macroagregates 
Microspheres (50μ) 
Bone Poliphosphate 
Monofluorphosphate 
Diphosphonate 
Pirophospate 
(MDP) Metilendiphosphonate  
Dynamic Studies Albumina 
Microspheres (0.5-4 μ) 
Tumors Bleomicine 
Tetracycline 
Citrate 
Spleen  Red Blood Cell Markers 
Spleen and Bile Vitamine B6 glutamic 
HIDA (Hepatobiliary IminoDiacetic Acid) 
Blood Pool 99mTc  Albumina 
White Blood Cell  or platelets 
(infection or inflammation)  
99mTc HMPAO (HexaMethylPropileneAmineOxime) 
Table 4. Radiuopharmaceuticals used with 99mTc for diagnostic studies. 
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8. Baby cyclotron characteristics  
Baby cyclotrons are known as a hospital equipment be cause they are build to fulfill the 
medical proposes, in general, they can afford until 4 targets to activated most of 
radioisotopes needs to do PET studies  
In Venezuelan experience the first installed cyclotron has the following characteristics:  
• Generated beam for activation: H +  
• Energy required for the activation: 9.6 MeV  
• Output  Beam minimal current: 50 μ A  
• Material to Activate: H218O  
• Activation Product: 18F-  (fluorine ion).  
• Running average activity: 800 mCi  
• Activation efficiency: Greater than 60% 
Also the device dimensions where 3.6 x 2 x 2 m3 for the acceleration d´s and inner shielding. 
And the room has to have at least 7 x 5 m2 only for the cyclotron and another 6 x 5 m2 for the 
synthesis lab.  But the very concerning issue is the weight of the entire system, only in inner 
shielding it has 37 tons and the magnet alone has a weight of 11 tons the full system is over 
50 tons 
This cyclotron produce protons of 9.6 millions of electron volts (MeV) of energy with a 
maximum current of 50 μΑ, the target is made of oxigen to transmute to fluor. In this 
activation process there are some particles going out the path of the main beam so they have 
to be stopped by the inner shielding as to warranty 10 μSv/h at 1 m from shleding and 1 m 
from floor. Also the magnetic regulation permit 1 G at 6 m from the center of the D´s 
8.1 Venezuelan medical cyclotron 
In our experiences, the utmost importance matter in a Cyclotron is the Quality Assurance 
Program in which must be include:  
1. Electrical Aspects  
2. Mechanical and performance aspects and 
3. Radiation Safety Aspects 
In a broad approximation, we can say that: 
8.1.1 Electrical aspects that have to be under control are: 
• On/off switches 
• For operation  
• For Emergency 
• Failure Interlocks 
• Safety Interlocks 
• Audible alarm  
• Luminous alarm 
• Processing unit connection 
• Selfdiagnostic 
8.1.2 Mechanical and performance aspects to be under control are: 
• Radiofrequency 
• Driver 
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• Stability  
• Mechanical movements of inner and outer doors 
• Beam Energy 
• Output flux 
• Output dose and exposition  
• Target effectiveness 
• Activation effectiveness 
8.1.3 Radiation Safety aspects to be under control are:  
• Area classification and signs 
• Area monitorization 
• Personal dosimetry 
• Activation control 
• Airborne debris 
• Chimney 
• Personnel Medical Check up: 
• Previous to begin working in the facility 
• Annual (prevocational) check up 
• Posterior to end laboral relationship with the facility 
• Shielding 
• Radiation Safety Committee 
8.1.4  Daily journey: Also three aspects need to  be controlled step by step, 
accounting to:  
• Radioisotope Production 
• Handling radioactive material for studies  
• Possible emergency 
8.1.4.1 In radioisotope production  it must be carefully checked: 
• Pre-start conditions  
• Area and ventilation ducts monitoring during cyclotron is on 
• Activation and contamination control after cyclotron is turn off 
• Pre and post Hot Cell monitoring 
• Radioactive waste disposal entry and release record 
• Fractionation residues and contamination  
• Radioactive waste disposal 
• Place design  
• Waste classification 
• Decay rate  
• Free release dates  
8.1.4.2 Radioactive material handling for diagnostic studies 
• Total activity produced in a cyclotron run  
• Fractionation doses 
• Patient injection site and procedure 
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• Patient waiting room= Controlled area  
• Adverse reaction, contraindication, diabetic patients 
8.1.4.3 Possible emergencies 
• Coolling system failure 
• Door interlocks during cyclotron is on 
• In use production line rupture 
• Vial rupture 
• Inside hot cell 
• Inside fractionation hood 
• Outside 
8.1.4.4 Radioactive material spills 
• Inside hot cell 
• Inside fractionation hood 
• During transportation  
This a  resume of our general procedure manual, reproduced for physicians to know about 
all procedures that will be under their responsibility because they are legally, the 
responsible for the facility and its practices, as is establish in BSS and many other documents 
regarding medical practice. Here we only intent to introduce a general framework about 
medical cyclotrons so we will only mention some useful concepts and its application in a 
new facility. 
8.1.5  
Regarding to electrical aspects we must emphasize that failure interlock never must be 
deactivated, before the in charge expert check it out and solve the situation, only after 
he/she sign the log describing the solution, operation can continue. It is important to 
remember that ignoring this interlocks and alarms has conducted, many times, to major 
accidents injuring personnel and patients.  
Before turning on cyclotron for a production run, the following operation parameters must 
be checked:  
STEP ONE: MORNING CHECK OUT BEFORE TURNING CYCLOTRON ON: (EXAMPLE) 
 
Water leakage NO
Normal operative ventilation  OK
Electrical power on, stable and normal Control cabinet OK 
Rf cabinet OK 
Vacumm 7x10-7 mbar (7 x 10 -5 Pa) 
Water conductivity 5 μSiemens 
Water cooling temperature  20+2 ºC
Gas valves Production  Máx 0.5 MPa  (73 psi) 
Operation 3 +0.1 MPa (435 + 14 psi) 
Transport 0.5 +0.2 MPa (73 +29 psi) 
Shielding closed OK
Nobody in OK
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Cyclotron door closed OK
Room door closed OK
Safety system on (green)  OK
8.1.6 
On mechanical and performance settings it is important to become religious with the daily 
log for parameters to be safely establish before start working, to be sure of, what we want to 
obtain is what we really will obtain after cyclotron runs in the desire conditions 
STEP TWO: TUNNING ON CYCLOTRON   (EXAMPLE) 
 
Turn on all the computers  
Run autocheck  
Define in the console Current  
Irradiation time  
Charge  
Activity  
Target water level   
8.1.7 
For personnel safety there exist three types of emergency interlocks: 
• Radiological emergency:  as described  
• Ergonomical emergency:  as feet trapped under the cyclotron doors 
• Nature emergency: earthquake, flood, etc  
8.1.8 
In radiation safety aspects it is important to notice that radiation protection is not a solely 
part body but a team work . Everybody in the facility must be involved in Radiation 
Protection (RP) tasks and in the Radiation Safety (RS) Program and must be accomplish this 
minimal recommendations:  
RADIATION PROTECTION BASIC RECOMMENDATIONS: (EXAMPLE) 
 
1. Use your badge all the time you are in the facility (body, ring, alarm dosimeters)  
2. Use also the handy personal monitor that has been assign to you anytime you access 
the supervised and controlled areas 
3. Inside cyclotron room, hot lab and  fractionation lab, use cloak, glove and glasses   
4. Do not use decorative rings (jewelry), scarf, bracelet or any other accessory that could 
transport contamination outward  
5. Never get in cyclotron room during production  
6. Never use mouth pipettes 
7. Never handle radioactive material outside cells or hoods 
8. Use long forceps or tweezers 
9. Never use controlled fridge for food or beverage 
10. Radioactive waste must be dispose by its nature and classification in the selected area 
for them  
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11. Monitor your working area before and after each assignation and whenever a 
contamination is suspected  
12. Wash your hands before living controlled area 
13. Monitor your hands before living controlled area and return to 12 until background 
is reached. In any case contact RSO  
14. Record every activity (cyclotron, Hot Lab, Synthsys lab, Fractionation Lab) in 
corresponding log 
15. Any unusual event must be report in corresponding log  
16. In any radiological event communication chain must be follow 
17. In case of inhalation or ingestion follew corresponding emergency procedure as it is 
written  
8.1.8.1 
In such a large facility it is mandatory to exist an ad hoc committee known s “Radiation 
Safety Committee” (RSC) as it is establish in Venezuelan safety standard NVC3299. In our 
case, this comitte must ever be conformed by: 
1. Radiation Safety Officer 
2. One delegate from maintenance and engineering department 
3. One delegate from directive or administrative board 
4. One delegated of security department  
5. One delegate from technician staff 
6. One delegate from nursing staff 
7. One delegated from physician (at least) 
Many other specialist, physician, physicist, chemist can be include 
8.1.8.2 
For radiation area classification, national standard recommendation will be follow as in 
NVC 2257: Any area must be classified as “Controlled” if in any moment of daily operation 
the exposition rate is above 0.5 mR/h. In this sense , cyclotron room, synthesis lab, hot lab, 
injection room pet/ct room are controlled areas by default. Classification of different areas 
will be consult to RSC and RSO and will be solve only after 24 h continuous measurements, 
and any other consideration in standard classification may be voted and solved by more that 
75% of delegates   
This is the figure that will take all the decisions regarding al RS concerns and its decisions 
must be voted to win with more of the 75% of the committee delegates.  
In radioisotope uses (for diagnostic or therapies) any patient application  can be supervised 
by committee  and logs must be all time up to date. All the details for all the task mentioned 
above must be clearly describe in each procedure manual and clearly understand by any of 
the participant of each task  
Notification chain must also be clearly establish and accomplish from personnel who needs 
to report,  thru RSO,  until the National Regulatory Authority 
8.1.8.3 Cyclotron Cycle 
• In cyclotron room protons hits water target transmuting  16O into 18F. 
•  In Hot Lab  18F ions are measured in activity, pureness, pyrogenicity, volume, etc  
• Synthesis Lab FDG is produced by substitution of oxygen  ion by the activated fluorine 
ion inside  the molecular chain yielding to labeled 18FDG  
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8.1.8.4 Parasite Activation  
One of the most relevant issues in Cyclotron facility is the activation of the materials inside 
the cyclotron room during daily operation. As cyclotron room is a close and hardly shielded 
facility all activation products will ever be contained inside its room and the activation 
levels will only be monitored and measured during providers maintenances, in this 
opportunity, frotis are taken of the most suitable materials to be activated and they are 
measure in spectrometer. On the other hand, gaseous activation is continuously monitored 
with proper devices set inside the chimney. As first defense line, the facility has a 200 m 
circuit through which gaseous particles travel  during 24 hours before getting into the 
chimney to be release to the atmosphere. As our cyclotron do not have gaseous target all the 
airborne particles come from the air inside the room, so they are characterized by their 
extremely short half lives, around nano or micro seconds. Periodcally, frotis are taken from 
the chimney to be measure in spectrometer.  
For any maintenance that need the “backdoor” of the cyclotron to be removed, exposition 
rate must be below 0.5 mR/h as it is establish in NVC2259. If it is not, maintenance 
personnel must wait until this level is reached. 
Finally, it must be said that in operation conditions Cyclotron is fully shielded allowing a 
maximum of 10 mSv at 1 m in the axial direction of the magnet, and  such a value is only 
reached one or twice a day in the production time that is less than 2 hours accounting  all 
the running.  
8.2 Synthesis laboratory  
In Pet studies a cyclotron is nothing without radiochemical laboratory , because cyclotron only 
produce the ion, in our case, 18F and it has to be joined to the glucose analogue  molecule 
(fluordexoxiglucose) to be driven to the body. In it  fluor is send into molecule via 
electrophilic fluorination or nucleophilic fluorination reaction in which stable fluor is 
substitute by the activated 18F.  
 
 
Fig. 11. Synthesis Lab in Venezuelan Cyclotron  facility (courtesy Dorly Coehlo) 
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8.3 Patient radiation protection  
Before finishing let´s have few words about the protection of patients. In patient protection 
we have to had in mind not only the physical half life because sometimes biological half life 
is longer and radiation protection must to be concern to the excretion system of patient so 
Nuclear Medicine define an effective half life to take into account the two contributions to 
patient doses coming from physical and biological behavior of radioisotope. Biological half 
live is the time living organism needs to excrete any radioisotope trace of radioactive 
material. It depends no only of physical time but on effectiveness of excretion system of the 
body. So effective life is : ͳଵܶ/ଶ௘௙௙ = ͳଵܶ/ଶ௣௛௬ + ͳଵܶ/ଶ௕௜௢ 
 
ISOTOPES HALF LIVES (days) 
TPhysical TBiological TEffective
3H 4.5 x 103 12 12 
14C 2.1 x 106 40 40 
22Na 850 11 11 
32P 14.3 1155 14.1 
35S 87.4 90 44.3 
36Cl 1.1 x 108 29 29 
45Ca 165 1.8 x 104 164 
59Fe 45 600 42 
60Co 1.93 x 103 10 10 
65Zn 244 933 193 
86Rb 18.8 45 13 
90Sr 1.1 x 104 1.8 x 104 6.8 x 104 
99mTc 0.25 1 0.20 
123I 0.54 138 0.54 
131I 8 138 7.6 
137Cs 1.1 x 104 70 70 
140Ba 12.8 65 10.7 
198Au 2.7 280 2.7 
210Po 138 60 42 
226Ra 5.8 x 105 1.6 x 104 1.5 x 104 
235U 2.6 x 1011 15 15 
239Pu 8.8 x 10 7.3 x 104 7.2 x 104 
Table 4. Physical and Biological half lives 
Radioisotopes like P and Sr like to stay in bone, so as far as they can be used to treat bone 
lesions the maximize its doses due to the combination of physical and biological exposure. 
Phosphorous decay faster so Sr is better to treat bone metastasis due to it relatively long 
physical and biological half life. For diagnostic studies Tc has proven to be the best due to its 
short physical and  biological lives, so it is excrete from the body just after images has be taken. 
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